相似文献
1
Authors' reply.作者回复。
Singapore Med J. 2019 Jun;60(6):323. doi: 10.11622/smedj.2019063.
2
Comment on: Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.关于《献血者和高危人群中丙型肝炎病毒感染率及IL28B基因多态性》的评论
Singapore Med J. 2019 Jun;60(6):323. doi: 10.11622/smedj.2019062.
3
Authors' reply: first-phase parameters in hepatitis C viral kinetics.
J Viral Hepat. 2002 Nov;9(6):466. doi: 10.1046/j.1365-2893.2002.00394.x.
4
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply.社论：无干扰素直接作用抗病毒药物对丙型肝炎和冷球蛋白血症患者是一大福音——作者回复。
Aliment Pharmacol Ther. 2018 Oct;48(7):772-773. doi: 10.1111/apt.14936.
5
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.社论：对于接受无干扰素直接作用抗病毒联合治疗的丙型肝炎患者，预测持续病毒学应答是否需要额外检测？作者回复。
Aliment Pharmacol Ther. 2018 Mar;47(6):849-850. doi: 10.1111/apt.14520.
6
[HCV genotypes in Polish blood donors in period 1995-2007].[1995 - 2007年波兰献血者中的丙型肝炎病毒基因型]
Przegl Epidemiol. 2008;62(1):163-9.
7
Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina.在波斯尼亚和黑塞哥维那东北部的慢性丙型肝炎患者和首次献血者中丙型肝炎病毒基因型。
Bosn J Basic Med Sci. 2009 Nov;9(4):278-82. doi: 10.17305/bjbms.2009.2779.
8
Genotypic distribution of hepatitis C virus in voluntary blood donors of northern Thailand.泰国北部无偿献血者中丙型肝炎病毒的基因分型分布
Southeast Asian J Trop Med Public Health. 2009 May;40(3):471-9.
9
Hepatitis C virus genotypes in French blood donors.法国献血者中的丙型肝炎病毒基因型
J Med Virol. 1995 Apr;45(4):399-404. doi: 10.1002/jmv.1890450408.
10
Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
Transfusion. 1997 Jan;37(1):73-8. doi: 10.1046/j.1537-2995.1997.37197176954.x.
本文引用的文献
1
Comment on: Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.关于《献血者和高危人群中丙型肝炎病毒感染率及IL28B基因多态性》的评论
Singapore Med J. 2019 Jun;60(6):323. doi: 10.11622/smedj.2019062.
2
Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.献血者和高危人群中丙型肝炎病毒感染及IL28B基因多态性的患病率
Singapore Med J. 2019 Jan;60(1):34-39. doi: 10.11622/smedj.2018078. Epub 2018 Jun 21.
3
Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable polymorphism.聚乙二醇干扰素和利巴韦林在具有有利多态性的丙型肝炎1型人群中的真实世界经验。
Gastroenterol Rep (Oxf). 2017 Aug;5(3):208-212. doi: 10.1093/gastro/gow033. Epub 2016 Oct 24.
4
Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian population.TLRs 和 IL-6 在突尼斯人群慢性丙型肝炎治疗结果中的作用。
Cytokine. 2017 Nov;99:297-304. doi: 10.1016/j.cyto.2017.08.010. Epub 2017 Aug 18.
5
Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience.慢性肝炎初治患者中，丙型肝炎病毒Q80K在NS3基线耐药相关氨基酸变异中占主导地位：单中心经验
Arch Virol. 2015 Nov;160(11):2881-5. doi: 10.1007/s00705-015-2563-3. Epub 2015 Aug 7.
6
Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.苏格兰队列中丙型肝炎病毒NS3治疗前耐药相关氨基酸变异的患病率。
J Clin Virol. 2015 Apr;65:50-3. doi: 10.1016/j.jcv.2015.02.005. Epub 2015 Feb 9.
Zotero 插件